Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.

Cells - 7 Sept 2021

Al-Sammarraie Nadia, Ray Swapan K

Abstract excerpt

Glioblastoma multiforme (GBM) is an aggressive malignancy of the brain and spinal cord with a poor life expectancy. The low survivability of GBM patients can be attributed, in part, to its heterogeneity and the presence of multiple genetic alterations causing rapid tumor growth and resistance to conventional therapy. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated (Cas)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Associated Protein 9
Share to CRISPR-Cas Systems
Share to Endonucleases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Editing

Share to Gene Transfer Techniques

Share to Genetic Therapy

Share to Glioblastoma

Share to Oncogenes

Source

Open in PubMed Open full text

Identifiers

PMID: 34571991
DOI: 10.3390/cells10092342
PMCID: PMC8468137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.PMID 34571991Read ↗

Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic ScreeningSemantic proximity Read ↗

Unlocking glioblastoma vulnerabilities with CRISPR-based genetic screeningSemantic proximity Read ↗

Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma StudiesSemantic proximity Read ↗

Glioblastoma: new therapeutic strategies to address cellular and genomic complexitySemantic proximity Read ↗

CRISPR-Cas9 Screen Reveals PSMB3 Contributes to Gliomagenesis Through Proteasome-Dependent and Independent MechanismsSemantic proximity Read ↗

Genome scale CRISPR Cas9a knockout screen reveals genes that controls glioblastoma susceptibility to the alkylating agent temozolomideSemantic proximity Read ↗

Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysisSemantic proximity Read ↗

Advanced Bioinformatics Analysis and Genetic Technologies for Targeting Autophagy in Glioblastoma MultiformeSemantic proximity Read ↗

Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastomaSemantic proximity Read ↗

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Semantic proximity Read ↗

AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.Semantic proximity Read ↗

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.